Joinn Laboratories(China)Co.,Ltd.

HKSE 6127.HK

Joinn Laboratories(China)Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.01

Joinn Laboratories(China)Co.,Ltd. Debt to Equity Ratio is 0.01 for the year ending December 31, 2023, a -52.75% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Joinn Laboratories(China)Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.01, a -19.77% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.01, a -33.10% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.02, a -26.08% change year over year.
  • Joinn Laboratories(China)Co.,Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.03, a 0.00% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
HKSE: 6127.HK

Joinn Laboratories(China)Co.,Ltd.

CEO Dr. Yuxia Feng M.D.
IPO Date Feb. 26, 2021
Location China
Headquarters A5 Rongjing East Street
Employees 2,510
Sector Health Care
Industries
Description

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

Similar companies

9995.HK

RemeGen Co., Ltd.

USD 1.59

2.46%

3759.HK

Pharmaron Beijing Co., Ltd.

USD 1.70

5.22%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 3.72

2.09%

StockViz Staff

January 16, 2025

Any question? Send us an email